Clinical trial

A Dose-escalation Study in Subjects With Pulmonary Arterial Hypertension (PAH)

NCT03177603

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2018-02-21

PhasePHASE2

Study timeline

Study start (actual)2018-02-21Date precision: day

Registry last updated2020-04-21

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Hypertension, Pulmonaryunresolved

Interventions

GSK2586881DRUG

Sponsors & collaborators

GlaxoSmithKlinelead sponsor

Mapped research locations

DallasTexas, United States1 MadridSpain1 BarcelonaSpain1 PittsburghPennsylvania, United States1 BerlinGermany1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03177603 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.